XML 41 R20.htm IDEA: XBRL DOCUMENT v3.22.2
Revenues (Tables)
 6 Months Ended
Jul. 01, 2022
Revenue from Contract with Customer [Abstract]  
Schedule of Disaggregation of Revenue
Revenues consisted of the following (in thousands):
Three Months Ended June 30,Six Months Ended June 30,
2022202120222021
Product revenues:
Gross product revenues$483,073 $380,204 $931,310 $694,409 
Discounts and allowances(136,029)(95,956)(273,968)(182,949)
Net product revenues347,044 284,248 657,342 511,460 
Collaboration revenues:
License revenues57,526 39,640 89,593 67,168 
Collaboration services revenues14,857 61,289 28,472 76,779 
Total collaboration revenues72,383 100,929 118,065 143,947 
Total revenues$419,427 $385,177 $775,407 $655,407 
Net product revenues by product were as follows (in thousands):
Three Months Ended June 30,Six Months Ended June 30,
2022202120222021
CABOMETYX$339,159 $275,614 $641,971 $499,209 
COMETRIQ7,885 8,634 15,371 12,251 
Net product revenues$347,044 $284,248 $657,342 $511,460 
Schedule of Concentration Risks
The percentage of total revenues by customer who individually accounted for 10% or more of our total revenues were as follows:
Three Months Ended June 30,Six Months Ended June 30,
2022202120222021
Affiliates of McKesson Corporation16 %14 %17 %14 %
Affiliates of CVS Health Corporation16 %13 %16 %14 %
Affiliates of AmerisourceBergen Corporation15 %12 %16 %13 %
Ipsen Pharma SAS15 %24 %12 %19 %
Accredo Health, Incorporated10 %8 %9 %8 %
The percentage of trade receivables by customer who individually accounted for 10% or more of our trade receivables were as follows:
June 30, 2022December 31, 2021
Ipsen Pharma SAS30 %50 %
Affiliates of McKesson Corporation17 %10 %
Affiliates of AmerisourceBergen Corporation14 %11 %
Affiliates of CVS Health Corporation14 %9 %
Cardinal Health10 %6 %
Schedule of Revenues Disaggregated by Geographic Region
Revenues by geographic region were as follows (in thousands):
Three Months Ended June 30,Six Months Ended June 30,
2022202120222021
U.S.$349,615 $287,190 $663,680 $517,147 
Europe62,240 90,921 96,767 124,727 
Japan7,572 7,066 14,960 13,533 
Total revenues$419,427 $385,177 $775,407 $655,407 
Schedule of Activities and Ending Reserve Balances for Significant Categories of Discounts and Allowances
The activities and ending reserve balances for each significant category of discounts and allowances, which constitute variable consideration, were as follows (in thousands):
Chargebacks, Discounts for Prompt Payment and Other
Other Customer Credits/Fees and Co-pay Assistance
Rebates
Total
Balance at December 31, 2021
$14,625 $8,875 $24,825 $48,325 
Provision related to sales made in:
Current period175,564 24,444 72,890 272,898 
Prior periods1,311 (168)(73)1,070 
Payments and customer credits issued(171,534)(22,186)(64,812)(258,532)
Balance at June 30, 2022
$19,966 $10,965 $32,830 $63,761 
Schedule of Other Assets and Other Liabilities Contract assets and liabilities were as follows (in thousands):
June 30, 2022December 31, 2021
Contract assets (1)
$394 $1,665 
Contract liabilities:
Current portion (2)
$7,513 $7,814 
Long-term portion (3)
7,209 8,739 
Total contract liabilities$14,722 $16,553 
____________________
(1)    Presented in other long-term assets in the accompanying Condensed Consolidated Balance Sheets.
(2)    Presented in other current liabilities in the accompanying Condensed Consolidated Balance Sheets.
(3)    Presented in the long-term portion of deferred revenues in the accompanying Condensed Consolidated Balance Sheets